EGFR and cancer: It has been shown that not only does EGF signaling promote EMT in OSCC cells [41, 47], but also that the cancer cells which are undergoing EMT express considerably lower levels of EGFR and are less susceptible to EGFR targeted therapies, which leads to their chemotherapeutic resistance [65].